Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral tolvaptan add-on in acute decompensated heart failure: randomized controlled trial
TCTR20210316012Phase 4Completed
- Sponsor
- N/A
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in acute decompensated heart failure (ADHF), sponsored by N/A. Started Nov 2020; status: completed.
02
Drugs
tolvaptan
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on TCTR20210316012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210316012.